It may also be prudent to consider conducting multiplex ligation probe amplification (MLPA) assay for the DMD gene in female patients with dilated cardiomyopathy, irrespective of the absence of overt muscle weakness, high CK levels, or family history of dystrophinopathy. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.